Journal of Clinical and Translational Hepatology

Papers
(The median citation count of Journal of Clinical and Translational Hepatology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies271
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease185
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options46
Liver Transplantation Beyond Milan Criteria45
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver44
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States35
Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis30
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review30
Macrophage Phenotypes and Hepatitis B Virus Infection29
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease29
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases28
What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective27
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study26
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD23
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?20
Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications20
Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study19
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak19
Antihepatic Fibrosis Drugs in Clinical Trials18
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy16
Management of Hepatorenal Syndrome: A Review16
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review16
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications16
Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise16
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease15
Statin-induced Liver Injury Patterns: A Clinical Review15
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome15
Guidelines for Prevention and Treatment of Chronic Hepatitis B14
Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review14
COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery13
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease13
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma13
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis12
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail12
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts11
Prevention of HBV Recurrence after Liver Transplant: A Review11
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update11
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome10
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence10
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease10
Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis10
A 3D Human Liver Model of Nonalcoholic Steatohepatitis10
Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review10
Guidelines for the Management of Cholestatic Liver Diseases (2021)9
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease9
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway9
Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents9
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists9
HEV and HBV Dual Infection: A Review9
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice9
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis9
Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B8
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City8
Infections in Alcoholic Hepatitis8
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates8
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges8
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma8
Body Building and Aminotransferase Elevations: A Review8
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review8
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally8
A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps7
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)7
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis7
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment7
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation7
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science7
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China7
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?7
Selective Androgen Receptor Modulators: An Emerging Liver Toxin7
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 20197
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling7
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update7
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver7
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases7
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease7
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma6
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy6
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis6
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study6
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection6
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure6
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease6
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice6
Clinical Considerations of Coagulopathy in Acute Liver Failure6
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review6
Hepatic Histoplasmosis: An Update6
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review6
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies6
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease6
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?6
A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01)6
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)6
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis5
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop5
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis5
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver5
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective5
Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time5
Elastography for Longitudinal Assessment of Liver Fibrosis after Antiviral Therapy: A Review5
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma5
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China5
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site5
Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics5
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure5
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma5
Targeted Mitochondrial Delivery to Hepatocytes: A Review5
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination5
2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus5
Erythroid Lineage Cells in the Liver: Novel Immune Regulators and Beyond5
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies5
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection5
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning5
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection5
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition5
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice5
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma5
Approaches to Assessing Burden in Caregivers of Patients with Cirrhosis5
Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis5
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China5
Update on Sphincter of Oddi Dysfunction: A Review5
Coronavirus Disease-2019 (COVID-19) and the Liver5
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA5
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions4
Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis4
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease4
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome4
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway4
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase4
Complementary and Alternative Medicine-related Drug-induced Liver Injury in Iran4
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection4
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center4
Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy4
Nonalcoholic Fatty Liver Disease after Liver Transplant4
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment4
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo4
Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure4
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence4
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?4
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis4
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study4
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation4
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype4
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India4
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis4
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life4
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)4
Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis4
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma4
Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome3
Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA3
Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms3
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis3
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway3
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients3
Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection3
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma3
Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis3
Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease3
A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients3
Alcohol and Metabolic-associated Fatty Liver Disease3
Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review3
Alcoholic Liver Disease and COVID-19 Pneumonia: A Case Series3
Noncanonical NF-κB Signaling Pathway in Liver Diseases3
Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review3
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China3
Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-center Study3
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic3
Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients3
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection3
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis3
Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy3
Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B3
Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores3
The Gut Microbiome and Ferroptosis in MAFLD3
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases3
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis3
Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study3
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites3
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease3
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions3
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research3
Employment and Patient Satisfaction after Liver Transplantation3
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss3
Functional Cure of Chronic Hepatitis B with Antiviral Treatment in Children having High-level Viremia and Normal or Mildly Elevated Serum Aminotransferase3
Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians3
Current Status and Analysis of Machine Learning in Hepatocellular Carcinoma3
Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma3
Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma2
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B2
Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis2
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?2
A Case Report of Alloimmune Hepatitis after Direct-acting Antiviral Treatment in a Liver Transplant Patient2
Association of TCF7L2 rs7903146 Gene Polymorphism with the Risk of NAFLD and CAD in the Chinese Han Population2
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)2
Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota2
Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier2
Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity2
Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway In Vivo and In vitro2
Hepatic Alarmins and Mitochondrial Dysfunction under Residual Hyperlipidemic Stress Lead to Irreversible NAFLD2
Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis2
HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters2
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?2
Hepatitis B Virus Induces Microtubule Stabilization to Promote Productive Infection through Upregulating Microtubule-associated Protein 1S2
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma2
Diagnostic Accuracy of the Apparent Diffusion Coefficient for Microvascular Invasion in Hepatocellular Carcinoma: A Meta-analysis2
Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging2
Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment2
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease2
Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Bioinformatics and the Role of NR6A1 in the Progression of HCC2
Seronegative Autoimmune Hepatitis2
Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease2
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review2
Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B2
Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm2
COVID-19 in Liver Transplant Recipients2
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury2
Prediction and Prevention of Post-hepatectomy Liver Failure: Where Do We Stand?2
STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway2
Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital2
UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults2
Drug-induced Fatty Liver Disease: Pathogenesis and Treatment2
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence2
Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report2
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia2
Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF2
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization2
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity2
Hepatic Arterioportal Fistulas: A Retrospective Analysis of 97 Cases2
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes2
Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis2
Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China2
Celiac Disease and Elevated Liver Enzymes: A Review2
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma2
Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis2
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population2
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents2
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients2
Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy2
CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis2
Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease2
Regulatory Effect of JAK2/STAT3 on the Immune Function of Endotoxin-tolerant Dendritic Cells and its Involvement in Acute Liver Failure2
A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma2
PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure2
Immunotherapy-induced Hepatotoxicity: A Review2
Metabolic-associated Fatty Liver Disease as Assessed by the Fatty Liver Index Among Migrant and Non-migrant Ghanaian Populations2
Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK2
Imaging Findings of Hepatic Ewing’s Sarcoma on Computed Tomography and Gadobenate Dimeglumine-enhanced Magnetic Resonance Imaging: A Case Report and Literature Review2
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment2
0.059597015380859